FILIDITI Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for FILIDITI with the United States Patent and Trademark Office. The USPTO has given the FILIDITI trademark a serial number of 87489034. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2021. This trademark is owned by Pfizer Inc.. The FILIDITI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
filiditi

General Information


Serial Number87489034
Word MarkFILIDITI
Filing DateWednesday, June 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, January 11, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, May 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020EXTENSION 5 GRANTED
Wednesday, May 13, 2020EXTENSION 5 FILED
Thursday, May 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 13, 2020TEAS EXTENSION RECEIVED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 24, 2019EXTENSION 4 GRANTED
Sunday, November 24, 2019EXTENSION 4 FILED
Sunday, November 24, 2019TEAS EXTENSION RECEIVED
Thursday, November 14, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, October 17, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2019EXTENSION 3 GRANTED
Wednesday, May 1, 2019EXTENSION 3 FILED
Wednesday, May 1, 2019TEAS EXTENSION RECEIVED
Friday, November 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 14, 2018EXTENSION 2 GRANTED
Wednesday, November 14, 2018EXTENSION 2 FILED
Wednesday, November 14, 2018TEAS EXTENSION RECEIVED
Wednesday, March 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 5, 2018EXTENSION 1 GRANTED
Monday, March 5, 2018EXTENSION 1 FILED
Monday, March 5, 2018TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2017ASSIGNED TO EXAMINER
Wednesday, June 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM